Siemens Healthineers AG

SHL1

Company Profile

  • Business description

    Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.

  • Contact

    Siemensstrasse 3
    ForchheimBY91301
    DEU

    T: +49 9131843385

    https://www.siemens-healthineers.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 September 2026

    Employees

    74,000

Stocks News & Analysis

stocks

Higher distribution from ASX income share

Solid long-term outlook.
stocks

Are ASX REITs the better way to own property?

Cheap valuations, strong yields and a changing Aussie property landscape.
stocks

Cheap Dividend Aristocrat has Fair Value raised after earnings

Dividend forecasts raised after balance sheet regains strength.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,283.101.100.01%
CAC 408,636.8013.76-0.16%
DAX 4026,440.31140.570.53%
Dow JONES (US)53,732.41107.58-0.20%
FTSE 10010,750.1122.56-0.21%
HKSE25,116.85279.66-1.10%
NASDAQ26,729.1673.86-0.28%
Nikkei 22569,050.73336.930.49%
NZX 50 Index13,761.4892.90-0.67%
S&P 5007,785.7613.23-0.17%
S&P/ASX 2009,079.700.400.00%
SSE Composite Index3,927.180.210.01%

Market Movers